VHL Ligand 14
VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].
Product Specifications
CAS Number
[2010986-87-3]
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Ligands for E3 Ligase
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vhl-ligand-14.html
Purity
99.93
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C([C@H]1N(C([C@@H](NC(C)=O)C(C)(C)C)=O)C[C@H](O)C1)N[C@H](C2=CC=C(C3=C(C)N=CS3)C=C2)C
Molecular Formula
C25H34N4O4S
Molecular Weight
486.63
Precautions
H315, H319, H320
References & Citations
[1]Hu J, et al., Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER) . J Med Chem. 2019 Feb 14;62 (3) :1420-1442.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Von Hippel-Lindau (VHL)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
bsm-62702R-BF488-02 100 µL
C7orf27 Recombinant Antibody, AbBy Fluor™ 488 Conjugated
Ask
View Details 
226266-01 50 µL
TET2 (KIAA1546, MDS, Methylcytosine dioxygenase TET2, Nbla00191, Probable methylcytosine dioxygenase TET2, Protein Ayu17 449, Tet 2, Tet methylcytosine dioxygenase 2, Tet Oncogene 2, Tet Oncogene Family Member 2, TET2, TET2_HUMAN) discontinued
Ask
View Details 
226266-02 100 µL
TET2 (KIAA1546, MDS, Methylcytosine dioxygenase TET2, Nbla00191, Probable methylcytosine dioxygenase TET2, Protein Ayu17 449, Tet 2, Tet methylcytosine dioxygenase 2, Tet Oncogene 2, Tet Oncogene Family Member 2, TET2, TET2_HUMAN) discontinued
Ask
View Details